UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020049
Receipt No. R000023155
Official scientific title of the study Randomized double-blind study for the effect of theaflavin on oral bacterial flora
Date of disclosure of the study information 2015/12/03
Last modified on 2019/03/01 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Randomized double-blind study for the effect of theaflavin on oral bacterial flora
Title of the study (Brief title) Randomized double-blind study for the effect of theaflavin on oral bacterial flora
Region
Japan

Condition
Condition Healthy volunteers
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To determine the effect of teaflavin on oral bacterial flora
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Periodontopathic-bacteria after taking teaflavin tablets for 3 or 6 weeks
(1.P.gingivalis 2.F.nucleatum)
Key secondary outcomes Following indicators after taking teaflavin tablets for 3 or 6 weeks
1) Gingival index:GI
2) Plaque index: PI
3) Bleeding on Probing: BOP
4) Cariogenic bacteria

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Theaflavin tablet,
8 mg/2tablets/day, 6 weeks
Interventions/Control_2 Placebo tablet,
0 mg/2 tablets/day, 6 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria 1. Subjects who are not appropriate to examine oral bacterial flora

2. Subjects who are not under treatment for dental caries and/or periodontal disease and have enough tooth (20 tooth<=)
Key exclusion criteria 1. Subjects who are under treatment with mouse rinse
2. Subjects with diabetes, CKD, gastrointestinal diseases, lung diseases and/or cancer.
3. Subjects who are not appropriate to amount and pH of saliva.
4. Subjects with dental caries and/or periodontal disease
5. Subjects using removable denture
6. Antibiotics
7. drug and/or alcohol dependence
8. Pregnancy and nursing
9. Subjects who participate in other clinical trials at the time of this study entry
Target sample size 56

Research contact person
Name of lead principal investigator Tatsuya Morimoto
Organization Pharmaceutical Science, University of Shizuoka
Division name Division of Molecular Medicine
Address 52-1 Yada, Suruga-ku, Shizuoka
TEL 0542645763
Email morimoto@u-shizuoka-ken.ac.jp

Public contact
Name of contact person Eiji Yoshikawa
Organization KSO Corporation
Division name Sales department
Address 1-9-7 Shibaura, Minato-ku, Tokyo
TEL 03-3452-7733
Homepage URL
Email yoshikawa@kso.co.jp

Sponsor
Institute University of Shizuoka
Institute
Department

Funding Source
Organization Shizuoka industrial foundation
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 03 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 27 Day
Anticipated trial start date
2015 Year 11 Month 28 Day
Last follow-up date
2016 Year 02 Month 28 Day
Date of closure to data entry
2016 Year 03 Month 03 Day
Date trial data considered complete
2016 Year 03 Month 16 Day
Date analysis concluded
2016 Year 03 Month 30 Day

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 03 Day
Last modified on
2019 Year 03 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023155